Gozellix Kit
Product Images NDC 84552-500

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Gozellix (NDC 84552-500). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Telix Innovations Sa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Gozellix 01)

This is a procedure for preparing a solution of Gozetotide for injection. It involves combining Gozetotide with an acetate buffer solution, ascorbic acid stabilizer, Gallium Ga 68 Gozetotide Injection, and other components according to specified volumes and instructions. The final solution is used for diagnostic purposes such as determining radiochemical purity.*

FDA Label Image

Figure 2 (Gozellix 02)

This text provides instructions for the preparation of GOZELLIX Configuration A. It involves the addition of various substances to different vials and solutions, including Gozetotide Acetate Buffer, Ascorbic Acid Stabilizer, Gallium Ga 68 Chloride, 0.9% Sodium Chloride Injection, and more. The process includes specific volumes, waiting times, and swirling procedures to ensure the proper mixing of components. Additionally, it references the determination of radiochemical purity, pH, and appearance for quality control purposes.*

FDA Label Image

Figure 3 (Gozellix 03)

This information provides a detailed set of instructions for configuring GOZELLIX, including the addition of various solutions and the specific volumes to be used. The process involves mixing Gozetotide Acetate Buffer with Ascorbic Acid Stabilizer, followed by adding Gozetotide Solution and Gallium Ga 68 Gozetotide Injection. The text further mentions steps like collecting, swirling, waiting, and performing tests like determining radiochemical purity and pH. The final step involves using Gallium Ga 68 Chloride Solution with 0.1 M HCl and 0.9% Sodium Chloride Injection to achieve a final volume of 10 mL.*

FDA Label Image

Figure 4 (Gozellix 04)

This text provides detailed instructions for the preparation of GOZELLIX - Configuration B, including components such as Gozetotide Acetate Buffer, Ascorbic Acid stabilizer, Galium Ga 68 Gozetotide Injection, and 0.9% Sodium Chloride Injection. The steps involve adding specific amounts of different components to various vials, inverting, swirling, and collecting samples for testing radiochemical purity, pH, and appearance. The final volume to be achieved is 10 mL.*

FDA Label Image

Figure 5 (Gozellix 05)

FDA Label Image

Chemical Structure (Gozellix 06)

FDA Label Image

Principal Display Panel (Kit Carton)

FDA Label Image

Principal Display Panel (Kit Carton)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.